Answers are grounded in this paper and cite their sources.
MRTK has a poor outcome especially in young and advanced-stage disease patients. Neither tumour volume at diagnosis, nor pre-operative chemosensitivity are prognostic factors for survival.
No takes yet. Share an insight, caveat, or question.
Heuvel‐Eibrink et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: